USFDA concludes BIMO inspection at Alkem Laboratories’ Bioequivalence Center

13 Mar 2025 Evaluate

U.S Food and Drug Administration (USFDA) has concluded a Bioresearch Monitoring (BIMO) inspection at Alkem Laboratories’ Bioequivalence Center located at Taloja, Maharashtra. The said inspection conducted from March 10, 2025 to March 13, 2025. At the end of the inspection, no Form 483 was issued. 

Alkem Laboratories is among India’s leading global pharmaceutical companies. The company develops, manufactures and markets high-quality pharmaceutical products across all major therapeutic segments.

Alkem Laboratories Share Price

4704.10 -46.25 (-0.97%)
13-Mar-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1683.85
Dr. Reddys Lab 1107.85
Cipla 1461.60
Lupin 1969.05
Zydus Lifesciences 882.55
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...